A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing

Ohm, Joyce E, McGarvey, Kelly M, Yu, Xiaobing, Cheng, Linzhao, Schuebel, Kornel E, Cope, Leslie, Mohammad, Helai P, Chen, Wei, Daniel, Vincent C, Yu, Wayne, Berman, David M, Jenuwein, Thomas, Pruitt, Kevin, Sharkis, Saul J, Watkins, D Neil, Herman, James G, Baylin, Stephen B·2007·Nature Genetics
DOI 10.1038/ng1972

Cited by (999)

Items 601–700 of 999

  1. Aberrant Epigenetic Silencing of Tumor Suppressor Genes Is Reversed by Direct Reprogramming
    Shulamit Ron-Bigger, Ori Bar‐Nur, Sara Isaac, Michael Bocker, Frank Lyko, Amir Eden · 2010 · Stem Cells
  2. Promoter Methylation in the Genesis of Gastrointestinal Cancer
    Clement Richard Boland, Sung Kwan Shin, Ajay Goel · 2009 · Yonsei Medical Journal
  3. BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer
    Eddy H.J. Van Roon, Arnoud Boot, Ashwin A. Dihal, Robert Frans Ernst, Tom van Wezel, Hans M. Morreau, Judith M. Boer · 2013 · Clinical Epigenetics
  4. RFX1 downregulation contributes to TLR4 overexpression in CD14+ monocytes via epigenetic mechanisms in coronary artery disease
    Pei Du, Keqin Gao, Yu Cao, Shuang Yang, Yang Wang, Ren Guo, Ming Zhao, Sujie Jia · 2019 · Clinical Epigenetics
  5. The Mitochondrial Protein VDAC1 at the Crossroads of Cancer Cell Metabolism: The Epigenetic Link
    Zohar Amsalem, Tasleem Arif, Anna Shteinfer‐Kuzmine, Vered Chalifa Caspi, Varda Shoshan‐Barmatz · 2020 · Cancers
  6. Transition to naïve human pluripotency mirrors pan-cancer DNA hypermethylation
    Hemalvi Patani, Michael D. Rushton, Jonathan Higham, Saúl Álvarez–Teijeiro, David Oxley, Pedro R. Cutillas, Duncan Sproul, Gabriella Ficz · 2020 · Nature Communications
  7. Chromatin Mechanisms Regulating Gene Expression in Health and Disease
    Constanze Bonifer, Peter N. Cockerill · 2011 · Advances in experimental medicine and biology
  8. Effects of non-CpG site methylation on DNA thermal stability: a fluorescence study
    Luca Nardo, Marco Lamperti, Domenico Salerno, Valeria Cassina, Natalia Missana, Maria Bondani, Alessia Tempestini, Francesco Mantegazza · 2015 · Nucleic Acids Research
  9. Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence
    Wei Xiao, Ji Wang, Heng Li, Ding Xia, Yu Gan, Weimin Yao, Yang Yang, Haibing Xiao, Bin Lang, Xin Ma et al. · 2014 · BMC Cancer
  10. Polycomb Repressive Complex 2 Regulates Lineage Fidelity during Embryonic Stem Cell Differentiation
    Seraphim R. Thornton, Vincent L. Butty, Stuart S. Levine, Laurie A. Boyer · 2014 · PLoS ONE
  11. Exploring the molecular aspects associated with testicular germ cell tumors: a review
    Gaetano Facchini, Sabrina Rossetti, Carla Cavaliere, Carmine D’Aniello, Rossella Di Franco, Gelsomina Iovane, Giovanni Grimaldi, Raffaele Piscitelli, Paolo Muto, Gerardo Botti et al. · 2017 · Oncotarget
  12. Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing ofCDX1andEPHBtumor suppressor genes in colorectal cancer
    Kerstin Rönsch, Marcel Jäger, Anja Schöpflin, Mihai Danciu, Silke Laßmann, Andreas Hecht · 2011 · Epigenetics
  13. Epigenetic regulation leading to induced pluripotency drives cancer development in vivo
    Kotaro Ohnishi, Katsunori Semi, Yasuhiro Yamada · 2014 · Biochemical and Biophysical Research Communications
  14. High‐wire act: the poised genome and cellular memory
    Deepika Puri, Hardik Gala, Rakesh K. Mishra, Jyotsna Dhawan · 2014 · FEBS Journal
  15. Integrated DNA methylation analysis identifies topographical and tumoral biomarkers in pilocytic astrocytomas
    Manila Antonelli, Antonio Fadda, Eleonora Loi, Loredana Moi, Cesare Zavattari, Pia Sulas, Davide Gentilini, Cinzia Cameli, Elena Bacchelli, Manuela Badiali et al. · 2018 · Oncotarget
  16. Defining, distinguishing and detecting the contribution of heterogeneous methylation to cancer heterogeneity
    Thomas R. Pisanic, Pornpat Athamanolap, Tza‐Huei Wang · 2016 · Seminars in Cell and Developmental Biology
  17. Transcriptional Regulator CNOT3 Defines an Aggressive Colorectal Cancer Subtype
    Paloma Cejas, Alessia Cavazza, C.N. Yandava, Victor Moreno, David A. Horst, Juan Moreno‐Rubio, Emilio Burgos, Marta Mendiola, Len Taing, Ajay Goel et al. · 2016 · Cancer Research
  18. Helicobacter pylori-infection-associated CpG island hypermethylation in the stomach and its possible association with Polycomb repressive marks
    Eun Joo Yoo, Seog-Yun Park, Nam‐Yun Cho, Nayoung Kim, Hye Seung Lee, Gyeong Hoon Kang · 2008 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  19. DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD 34+ CD 15− cells in early chronic‐phase chronic myeloid leukemia
    Stéphanie Maupetit‐Mehouas, Franck Court, Céline Bourgne, Agnès Guerci‐Bresler, Pascale Cony‐Makhoul, Hyacinthe Johnson, Gabriel Étienne, Philippe H. Rousselot, Denis Guyotat, Alexandre Janel et al. · 2018 · Molecular Oncology
  20. Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma
    Yongsheng Huang, Qian Yang, Yueyuan Zheng, Lehang Lin, Xin Xu, Xiu‐E Xu, Tiago C. Silva, Masaharu Hazawa, Li Peng, Haotian Cao et al. · 2021 · Nucleic Acids Research
  21. Epigenetic regulation of 5‐lipoxygenase in the phenotypic plasticity of valvular interstitial cells associated with aortic valve stenosis
    Edit Nagy, Magnus Bäck · 2012 · FEBS Letters
  22. The Importance Of Epigenetic Alterations In The Development Of Epstein-Barr Virus-Related Lymphomas
    Mária Takács, Judit Segesdi, Ferenc Bánáti, Anita Koroknai, Hans J. Wolf, Hans Helmut Niller, János Minárovits · 2009 · Mediterranean Journal of Hematology and Infectious Diseases
  23. Inhibition of DNA and Histone Methylation by 5-Aza-2′-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells
    Richard L. Momparler, Sylvie Côté, Louise F. Momparler, Youssef Idaghdour · 2017 · Frontiers in Oncology
  24. Mining Gene Expression Signature for the Detection of Pre-Malignant Melanocytes and Early Melanomas with Risk for Metastasis
    Camila Ferreira de Souza, Patrícia Batista Xander, Ana Carolina Monteiro, Amanda Gonçalves dos Santos Silva, Débora Castanheira Pereira da Silva, Sabine Mai, Viviane Bernardo, José Daniel Lopes, Miriam Galvonas Jasiulionis · 2012 · PLoS ONE
  25. Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment
    Iria Brocos‐Mosquera, Patrícia Miranda-Azpiazu, Carolina Muguruza, Virginia Corzo-Monje, Benito Morentín, J. Javier Meana, Luis Felipe Callado, Guadalupe Rivero · 2021 · Translational Psychiatry
  26. ARID1A loss-of-function induces CpG island methylator phenotype
    Harumi Yamada, Hideyuki Takeshima, Ryoji Fujiki, Satoshi Yamashita, Shigeki Sekine, Takayuki Ando, Naoko Hattori, Atsushi Okabe, Takaki Yoshikawa, Kazutaka Obama et al. · 2022 · Cancer Letters
  27. Characterizing crosstalk in epigenetic signaling to understand disease physiology
    Joanna K. Lempiäinen, Benjamin Aaron Garcia · 2023 · Biochemical Journal
  28. Translating biology into clinic: the case of glioblastoma
    Maria Maddalena Lino, Adrian Merlo · 2009 · Current Opinion in Cell Biology
  29. Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels
    Amy Guillaumet-Adkins, Julia Richter, Maria Dolores Odero, Juan Sandoval, Xabi Agirre, Albert Català, Manel Esteller, Felipe Prósper, Marı́a José Calasanz, Ismael Buño et al. · 2014 · Journal of Hematology & Oncology
  30. Epigenetic and genetic deregulation in cancer target distinct signaling pathway domains
    Yang Gao, Andrew Erich Teschendorff · 2016 · Nucleic Acids Research
  31. Genome‐wide DNA methylation analysis identifies MEGF10 as a novel epigenetically repressed candidate tumor suppressor gene in neuroblastoma
    Jessica Charlet, Ayumi Tomari, Anthony R. Dallosso, Marianna Szemes, Martina Kaselova, Thomas J. Curry, Bader O. Almutairi, Heather Etchevers, Carmel M. McConville, Karim T. A. Malik et al. · 2016 · Molecular Carcinogenesis
  32. Chapter 4 The Role of the Epigenetic Signal, DNA Methylation, in Gene Regulation During Erythroid Development
    Gordon D. Ginder, Merlin Nithya Gnanapragasam, Omar Y. Mian · 2008 · Current topics in developmental biology/Current Topics in Developmental Biology
  33. Genome-wide positioning of bivalent mononucleosomes
    Subhojit Sen, Kirsten F. Block, Alice Pasini, Stephen B. Baylin, Hariharan Easwaran · 2016 · BMC Medical Genomics
  34. The role of DNA methylation in personalized medicine for immune-related diseases
    Manoj Kumar Gupta, He Peng, Yang Li, Cheng‐Jian Xu · 2023 · Pharmacology & Therapeutics
  35. On epigenetic stochasticity, entropy and cancer risk
    Andrew Erich Teschendorff · 2024 · Philosophical Transactions of the Royal Society B Biological Sciences
  36. Cancer-associated DNA hypermethylation of Polycomb targets requires DNMT3A dual recognition of histone H2AK119 ubiquitination and the nucleosome acidic patch
    Kristjan H. Gretarsson, Stephen Abini-Agbomson, Susan L. Gloor, Daniel N. Weinberg, Jamie L McCuiston, Vishnu U. Sunitha Kumary, Allison R. Hickman, Varun Sahu, Rachel Lee, Xinjing Xu et al. · 2024 · Science Advances
  37. Promoter hypermethylation and loss ofCD133gene expression in colorectal cancers
    You-Kyung Jeon · 2010 · World Journal of Gastroenterology
  38. Reducing DNA methylation suppresses colon carcinogenesis by inducing tumor cell differentiation
    Yuichiro Hatano, Katsunori Semi, Kyoichi Hashimoto, Myeong Sup Lee, Akihiro Hirata, Hiroyuki Tomita, Toshiya Kuno, Manabu Takamatsu, Koji Aoki, Makoto Mark Taketo et al. · 2015 · Carcinogenesis
  39. DNA methylation variation along the cancer epigenome and the identification of novel epigenetic driver events
    Richard Heery, Martin H. Schaefer · 2021 · Nucleic Acids Research
  40. Epigenetic aspects of MDS and its molecular targeted therapy
    Jumpei Yamazaki, Jean‐Pierre J. Issa · 2012 · International Journal of Hematology
  41. Polycomb Group Protein Bmi1 Promotes Hematopoietic Cell Development from Embryonic Stem Cells
    Xiaolei Ding, Qiong Lin, Roberto Enseñat‐Waser, Stefan Rose‐John, Martin Zenke · 2011 · Stem Cells and Development
  42. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review
    Sumihito Nobusawa, Junko Hirato, Hideaki Yokoo · 2014 · Brain Tumor Pathology
  43. Promoter Methylation Analysis Reveals That KCNA5 Ion Channel Silencing Supports Ewing Sarcoma Cell Proliferation
    Katherine Elizabeth Ryland, Allegra G. Hawkins, Daniel J. Weisenberger, Vasu Punj, Scott C. Borinstein, Peter W. Laird, Jeffrey R. Martens, Elizabeth R. Lawlor · 2015 · Molecular Cancer Research
  44. X inactivation and disease.
    R. Agrelo, A. Wutz · 2010 · Seminars in Cell and Developmental Biology
  45. Epigenetic Changes in Cancer as Potential Targets for Prophylaxis and Maintenance Therapy
    Kirsten Grønbæk, Marianne Bach Treppendahl, Fazila Asmar, Per Guldberg · 2008 · Basic & Clinical Pharmacology & Toxicology
  46. Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma
    Bethany L. Mundy-Bosse, Christoph Weigel, Yue-Zhong Wu, Salma Abdelbaky, Youssef Youssef, Susana Beceiro Casas, Nicholas Polley, Gabrielle Ernst, Karen A. Young, Kathleen K. McConnell et al. · 2022 · Blood Cancer Discovery
  47. Targeting epigenetic alterations in cancer stem cells
    Francesco Verona, Vincenzo Davide Pantina, Chiara Modica, Lo Iacono M., Caterina D’Accardo, Gaetana Porcelli, Dario Cricchio, Alice Turdo, Miriam Gaggianesi, Simone Di Franco et al. · 2022 · Frontiers in Molecular Medicine
  48. A Cancer Reprogramming Method Using MicroRNAs as a Novel Therapeutic Approach against Colon Cancer
    Susumu Miyazaki, Hirofumi Yamamoto, Norikatsu Miyoshi, Xin Wu, Hisataka Ogawa, Mamoru Uemura, Junichi Nishimura, Taishi Hata, Ichiro Takemasa, Tsunekazu Mizushima et al. · 2014 · Annals of Surgical Oncology
  49. Histone methylation is a critical regulator of the abnormal expression of POU5F1 and RASSF1A in testis cancer cell lines
    Romain Lambrot, Sarah Kimmins · 2010 · International Journal of Andrology
  50. Promoter methylation patterns in R ichter syndrome affect stem‐cell maintenance and cell cycle regulation and differ from de novo diffuse large B ‐cell lymphoma
    Andrea Rinaldi, Afua A. Mensah, Ivo Kwee, Francesco Forconi, Ester Maria Orlandi, Marco Lucioni, Valter Gattei, Roberto Marasca, Françoise Berger, Sergio Cogliatti et al. · 2013 · British Journal of Haematology
  51. Epigenetics of Neurological Cancers
    Shaun D. Fouse, J Costello · 2009 · Future Oncology
  52. Keeping an open mind: highlights and controversies of the breast cancer stem cell theory
    Cinzia Allegrucci, Mansi Shah · 2012 · Breast Cancer Targets and Therapy
  53. Identification of novel DNA methylation inhibitors via a two-component reporter gene system
    Yi-Shiuan Lin, Arthur Y. Shaw, Shigang Wang, Chia‐Chen Hsu, I-Wen Teng, Min‐Jen Tseng, Tim H.‐M. Huang, Ching‐Shih Chen, Yu‐Wei Leu, Shu‐Huei Hsiao · 2011 · Journal of Biomedical Science
  54. Epigenetic regulation of protein glycosylation
    Vlatka Zoldoš, Srđana Grgurević, Gordan Lauc · 2010 · BioMolecular Concepts
  55. Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer
    Keishi Sugimachi, Tae Matsumura, Teppei Shimamura, Hidenari Hirata, Ryutaro Uchi, Masami Ueda, Shotaro Sakimura, Tomohiro Iguchi, Hidetoshi Eguchi, Takaaki Masuda et al. · 2016 · Annals of Surgical Oncology
  56. Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression
    Tianyuan Liu, Xuan Zhao, Yuan Lin, Qi Luo, Shaosen Zhang, Yiyi Xi, Yamei Chen, Lin Lin, Wenyi Fan, Jie Yang et al. · 2022 · Cancer Research
  57. Clonal Evolution in Healthy and Premalignant Tissues: Implications for Early Cancer Interception Strategies
    Jayant K. Rane, Alexander M. Frankell, Clare E. Weeden, Charles Swanton · 2023 · Cancer Prevention Research
  58. Polycomb and the Emerging Epigenetics of Pancreatic Cancer
    Adrienne L. Grzenda, Tamás Ördög, Raul A. Urrutia · 2011 · Journal of Gastrointestinal Cancer
  59. The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation
    Cláudia Regina Gasque Schoof, Alberto Izzotti, Miriam Galvonas Jasiulionis, L.R. Vasques · 2015 · BioMed Research International
  60. Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer
    Steffen Kiehl, Tobias Zimmermann, Rajkumar Savai, Soni Savai Pullamsetti, Werner Seeger, Marek Bartkuhn, Reinhard Dammann · 2017 · Scientific Reports
  61. Dynamic Signatures of the Epigenome: Friend or Foe?
    Marta Machnik, Urszula Oleksiewicz · 2020 · Cells
  62. Chromatin remodeling by the histone methyltransferase EZH2 drives lung pre-malignancy and is a target for cancer prevention
    Carmen S. Tellez, Maria A. Picchi, Daniel E. Juri, Kieu Do, Dhimant H. Desai, Shantu Amin, Julie A. Hutt, Piotr Teodor Filipczak, Steven A. Belinsky · 2021 · Clinical Epigenetics
  63. Corruption of the Intra-Gene DNA Methylation Architecture Is a Hallmark of Cancer
    Thomas E. Bartlett, Alexey A. Zaikin, Sofia C. Olhede, James West, Andrew Erich Teschendorff, Martin Widschwendter · 2013 · PLoS ONE
  64. Systems biology and cancer stem cells
    Nathan D. Price, Greg Foltz, Anup Madan, Leroy Hood, Qiang Tian · 2007 · Journal of Cellular and Molecular Medicine
  65. PRC2 clock: a universal epigenetic biomarker of aging and rejuvenation
    Moqri, Mahdi, Cipriano, Andrea, Nachun, Daniel, Murty, Tara, de Sena Brandine, Guilherme, Rasouli, Sajede, Tarkhov, Andrei, Aberg, Karolina A., van den Oord, Edwin, Zhou, Wanding et al. · 2022
  66. SIRT1 affects DNA methylation of polycomb group protein target genes, a hotspot of the epigenetic shift observed in ageing
    Luisa Anne Wakeling, Laura Jane Ions, Suzanne M Escolme, Simon Cockell, Tianhong Su, Madhurima Dey, Emily V Hampton, Gail Jenkins, Linda Wainwright, Jill A. McKay et al. · 2015 · Human Genomics
  67. Methods for Cancer Epigenome Analysis
    Raman P. Nagarajan, Shaun D. Fouse, Robert J.A. Bell, J Costello · 2012 · Advances in experimental medicine and biology
  68. Genes involved in development and differentiation are commonly methylated in cancers derived from multiple organs: A single-institutional methylome analysis using 1007 tissue specimens
    Kentaro Ohara, Eri Arai, Yoriko Takahashi, Nanako Ito, Ayako Shibuya, Koji Tsuta, Ryoji Kushima, Hitoshi Tsuda, Hidenori Ojima, Hiroyuki Fujimoto et al. · 2017 · Carcinogenesis
  69. Targeting DNA Methylation Depletes Uterine Leiomyoma Stem Cell–enriched Population by Stimulating Their Differentiation
    Shimeng Liu, Ping Yin, Jingting Xu, Ariel J. Dotts, Stacy Ann Kujawa, John Sayler Coon, Hong Zhao, Ali Shilatifard, Yang David Dai, Serdar Ekrem Bulun · 2020 · Endocrinology
  70. Epigenetic Biomarkers
    Timothy An-thy Chan, Stephen B. Baylin · 2010 · Current topics in microbiology and immunology
  71. Role of epigenetic modulation in cancer stem cell fate
    Abhijeet P. Deshmukh, Mudra Binju, Frank Arfuso, Philip Newsholme, Arun Dharmarajan · 2017 · The International Journal of Biochemistry & Cell Biology
  72. Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2
    Ming Li, Yi Tang, Qingshu Li, Ming Xiao, Yaying Yang, Yalan Wang · 2019 · Oncogene
  73. Developmental and epigenetic regulation of the human TLR3 gene
    Analı́a Porrás, Sarah Kozar, Valya R. RUSSANOVA, Paraskevi Salpea, Tazuko H. Hirai, Nicholas Sammons, Pooja Mittal, Ji Young Kim, Keiko Ozato, Roberto J. Romero et al. · 2008 · Molecular Immunology
  74. Distinct epigenetic regulation of tumor suppressor genes in putative cancer stem cells of solid tumors
    Soejima · 2010 · International Journal of Oncology
  75. Inactive or moderately active human promoters are enriched for inter-individual epialleles
    Carolina Gemma, Sreeram V. Ramagopalan, Thomas A. Down, Huriya Beyan, Mohammed Iqbal Hawa, Michelle L. Holland, Paul J. Hurd, Gavin Giovannoni, Richard David Leslie, George C. Ebers et al. · 2013 · Genome biology
  76. Epigenetics and Disease
    Susan M. Gasser, En Li · 2010 · Springer eBooks
  77. Pathogenic Impacts of Dysregulated Polycomb Repressive Complex Function in Hematological Malignancies
    Satoshi Kaito, Atsushi Iwama · 2020 · International Journal of Molecular Sciences
  78. Progesterone receptor-DNA methylation crosstalk regulates depletion of uterine leiomyoma stem cells: A potential therapeutic target
    Shimeng Liu, Ping Yin, Jingting Xu, Ariel J. Dotts, Stacy Ann Kujawa, John Sayler Coon, Hong Zhao, Yang David Dai, Serdar Ekrem Bulun · 2021 · Stem Cell Reports
  79. Epigenetic modulation of the HeLa cell membrane N-glycome
    Tomislav Horvat, Ana Mužinić, Darko Barišić, Maja Herak Bosnar, Vlatka Zoldoš · 2011 · Biochimica et Biophysica Acta (BBA) - General Subjects
  80. DNA methyl transferase I acts as a negative regulator of allergic skin inflammation
    Youngmi Kim, Kyungjong Kim, Deokbum Park, Eunmi Lee, Hansoo Lee, Yun‐Sil Lee, Jongseon Choe, Young‐Myeong Kim, Dooil Jeoung · 2012 · Molecular Immunology
  81. β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
    Dipika R. Mohan, Kleiton Silva Borges, Isabella Finco, Christopher Ryan LaPensee, Juilee Rege, April L. Solon, Donald W. Little, Tobias Else, Madson Queiroz Almeida, Derek Dang et al. · 2023 · Cancer Research
  82. Plasticity of melanoma cells induced by neural cell crest conditions and three-dimensional growth
    Stéphanie Ghislin, Frédérique Deshayes, Jessica Lauriol, Sandrine Middendorp, Isabelle Martins, Reem Al‐Daccak, Catherine Alcaïde‐Loridan · 2012 · Melanoma Research
  83. Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system
    Rebekka Unland, Kornelius Kerl, Sabrina Schlosser, Nicole Farwick, Tanja Plagemann, B Lechtape, Steven C. Clifford, Jonas H. Kreth, Joachim Gerß, Jörg Mühlisch et al. · 2013 · Journal of Neuro-Oncology
  84. Epigenetic Signatures In Stem Cells And Cancer Stem Cells
    Héctor Hernández‐Vargas, Nino Sinčić, Maria Ouzounova, Zdenko Herceg · 2009 · Epigenomics
  85. Clinical Significance of Epigenetic Alterations in Human Hepatocellular Carcinoma and Its Association with Genetic Mutations
    Naoshi Nishida, Masatoshi Kudo · 2016 · Digestive Diseases
  86. Stem cells, cancer, and epigenetics
    Baylin · 2009 · StemBook
  87. Cancer: evolutionary, genetic and epigenetic aspects
    A. V. Lichtenstein · 2010 · Clinical Epigenetics
  88. Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network
    E. Signaroldi, Pasquale Laise, Silvia Cristofanon, Arianna Brancaccio, Elisa Reisoli, Sina Atashpaz, Maria Rosa Terreni, Claudio Doglioni, Giancarlo Pruneri, Paolo Malatesta et al. · 2016 · Nature Communications
  89. The Role of H3K4 Trimethylation in CpG Islands Hypermethylation in Cancer
    Giuseppe Zardo · 2021 · Biomolecules
  90. Influence of IL1B polymorphism on CpG island hypermethylation in Helicobacter pylori-infected gastric cancer
    Eun Joo Yoo, Seog-Yun Park, Nam‐Yun Cho, Nayoung Kim, Hye Seung Lee, Donguk Kim, Gyeong Hoon Kang · 2010 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  91. Ring1B Promotes Hepatic Stem/Progenitor Cell Expansion Through Simultaneous Suppression of Cdkn1a and Cdkn2a in Mice
    Hiroyuki Koike, Yasuharu Ueno, Takako Naito, Tomoya Shiina, Susumu Nakata, Rie Ouchi, Yuta Obana, Keisuke Sekine, Yun‐Wen Zheng, Takanori Takebe et al. · 2014 · Hepatology
  92. Colorectal cancer stem cells
    Paul R. Salama, Cameron F E Platell · 2009 · ANZ Journal of Surgery
  93. Epigenetic approaches to regeneration of bone and cartilage from stem cells
    Gun‐Il Im, Kyung-Ju Shin · 2014 · Expert Opinion on Biological Therapy
  94. Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapy
    Wenjing Bai, Jinxin Xu, Wenbin Gu, Danyang Wang, Ying Cui, Weidong Rong, Xiaoan Du, Mingqiang Li, Cuicui Xia, Qingqing Gan et al. · 2025 · Nature Communications
  95. Reprogramming cancer cells to pluripotency
    Stefan H. Stricker, Steven M. Pollard · 2014 · Epigenetics
  96. The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer
    Wenfan Zhang, Huiling Cao, Jin‐Hao Yang, Jing Tai Zhao, Zheng Liang, Xiaodong Kang, Rong Wang · 2022 · BMC Cancer
  97. A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancer
    Jacob A. Schwartzman, Solange Mongoue‐Tchokote, Angela Gibbs, Lina Gao, Christopher L. Corless, Jennifer M. Jin, Luai R. Zarour, Celestia S. Higano, Lawrence D. True, Robert L. Vessella et al. · 2011 · Epigenetics
  98. Differential Antineoplastic Effects of Butyrate in Cells With and Without a Functioning DNA Mismatch Repair
    Shridhar S. Dronamraju, Jonathan M Coxhead, Seamus B. Kelly, John Cummings Mathers · 2009 · Nutrition and Cancer
  99. Causes, effects, and clinical implications of perturbed patterns within the cancer epigenome
    Urszula Oleksiewicz, Marta Machnik · 2020 · Seminars in Cancer Biology
  100. Integrative epigenome analysis identifies a Polycomb-targeted differentiation program as a tumor-suppressor event epigenetically inactivated in colorectal cancer
    Jing Ying Tan, Xiaojing Yang, Xia Jiang, Jianbiao Zhou, Zhuocheng Li, P L Lee, Baojie Li, Paul Robson, Qiang Yu · 2014 · Cell Death and Disease